A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
Clinical trial NCT01830543 · COMPLETED
Trial details
- NCT number
- NCT01830543
- Sponsor
- Janssen Scientific Affairs, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-10
- Primary completion
- 2016-07-28
- Enrollment
- 2124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.